GlassScriptPhysician profile
Adam Gregory Mogil
NPI 1245345933
$17,793.11
in general payments reported to CMS, 2019-2025
48 companies · $2,225 in 2025
The $2,225 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,369 · 2022: $2,450 · 2023: $1,723 · 2024: $8,026 · 2025: $2,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,821 · Travel and Lodging: $2,827 · Consulting Fee: $1,680 · Honoraria: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,821.13 |
| Travel and Lodging | $2,826.90 |
| Consulting Fee | $1,680.00 |
| Honoraria | $1,646.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,081.33 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $2,087.21 | 2021-2024 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $1,688.44 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $881.24 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Dendreon Pharmaceuticals LLC | $847.28 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $755.88 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $722.16 | 2021-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $662.06 | 2021-2025 | Xtandi, Myrbetriq |
| Blue Earth Diagnostics | $627.25 | 2021-2025 | Posluma |
| Teleflex LLC | $471.63 | 2021-2025 | Barrigel, Urolift |
| Abbvie INC. | $395.81 | 2021-2025 | |
| Myovant Sciences INC. | $317.87 | 2021-2022 | |
| Antares Pharma, INC. | $315.08 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Sun Pharmaceutical Industries INC. | $268.41 | 2022-2025 | Yonsa |
| Bayer Healthcare Pharmaceuticals INC. | $221.82 | 2022-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $192.64 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $172.84 | 2021-2025 | Pylarify |
| Acerus Pharmaceuticals Corporation | $149.43 | 2021-2022 | |
| Urovant Sciences INC | $143.77 | 2022 | |
| Endo USA, INC. | $138.58 | 2024-2025 | Xiaflex, Aveed |
| Rochester Medical Corporation | $119.25 | 2022 | |
| Foundation Medicine, INC. | $115.88 | 2023 | |
| Urogen Pharma, INC. | $108.54 | 2023-2025 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $103.72 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $93.41 | 2025 | Tlando, Trelstar |
| Telix Pharmaceuticals | $89.14 | 2025 | Illuccix |
| Immunitybio, INC. | $86.24 | 2024-2025 | |
| Clarus Therapeutics INC. | $85.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $83.77 | 2023-2025 | |
| Axonics, INC. | $67.84 | 2022 | |
| Abc Home Medical Supply, INC. | $63.61 | 2022-2023 | |
| C. R. Bard, INC. & Subsidiaries | $62.28 | 2023-2025 | Bard Urinary Drainage Bag |
| Olympus America INC. | $55.60 | 2021-2025 | Itind System |
| Allergan, INC. | $55.38 | 2021 | |
| Boston Scientific Corporation | $52.68 | 2024-2025 | Ams 700 |
| Coloplast Corp | $52.27 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $47.50 | 2024-2025 | Azmiro, Horizant |
| Halozyme INC | $42.54 | 2023 | |
| Becton, Dickinson and Company | $41.20 | 2024 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $39.47 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $38.83 | 2021-2023 | Lynparza |
| Palette Life Sciences, INC. | $27.00 | 2022 | |
| Calyxo, INC. | $23.82 | 2025 | Cvac Aspiration System |
| Convatec INC. | $22.09 | 2023 | |
| Alnylam Pharmaceuticals INC. | $21.48 | 2021 | |
| Travere Therapeutics, INC. | $20.63 | 2021 | |
| Hollister Incorporated | $17.51 | 2023 | Infyna Chic, Vapro |
| Tolmar, INC. | $14.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Mogil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.